Intervention Review

Heliox for treatment of exacerbations of chronic obstructive pulmonary disease

  1. Gustavo J. Rodrigo1,*,
  2. Charles V Pollack2,
  3. Carlos Rodrigo3,
  4. Brian H Rowe4,
  5. E. Haydn Walters5

Editorial Group: Cochrane Airways Group

Published Online: 22 JAN 2001

Assessed as up-to-date: 26 SEP 2002

DOI: 10.1002/14651858.CD003571

How to Cite

Rodrigo GJ, Pollack CV, Rodrigo C, Rowe BH, Walters EH. Heliox for treatment of exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD003571. DOI: 10.1002/14651858.CD003571.

Author Information

  1. 1

    Montevideo, Uruguay

  2. 2

    Pennsylvania Hospital, Department of Emergency Medicine, Philadelphia, USA

  3. 3

    Sociedad Española Primera en Socorros Mutuos, Unidad de Cuidados Intensivos, Montevideo, Uruguay

  4. 4

    University of Alberta, Department of Emergency Medicine, Edmonton, Alberta, Canada

  5. 5

    University of Tasmania Medical School, Discipline of Medicine, Hobart, Tasmania, Australia

*Gustavo J. Rodrigo, Obligado 1180, Ap. 203, Montevideo, 11300, Uruguay.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 JAN 2001


Cited in:


This article has been cited by:

  1. 1
    Cory A. Brulotte, Eddy S. Lang, Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Emergency Department, Emergency Medicine Clinics of North America, 2012, 30, 2, 223


  2. 2
    Eleanor J Molloy, Naomi McCallion, Colm PF O'Donnell, Peter G Davis, Heliox for prevention of morbidity and mortality in ventilated newborn infants, The Cochrane Library,